CD4+ T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein

Infection and Immunity

Volumn 67, Issue 11, 1999, Pages 5604-5614

  Charoenvit, Yupin ^a   Majam, Victoria Fallarme ^a,b   Corradin, Giampietro ^c   Sacci Jr , John B ^a,d   Wang, Ruobing ^a,b   Doolan, Denise L ^a,e   Jones, Trevor R ^a   Abot, Esteban ^a,b   Patarroyo, Manuel E ^f   Guzman, Fanny ^f   Hoffman, Stephen L ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e PAN AMERICAN HEALTH ORGANIZATION   (United States)

^f UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GAMMA INTERFERON; MEMBRANE PROTEIN; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; LIVER CELL; MALARIA; MOUSE; NONHUMAN; PLASMODIUM YOELII; PRIORITY JOURNAL; SPOROZOITE; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0032726681     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.11.5604-5614.1999     Document Type: Article

References (32)

1. Charoenvit, Y., W. E. Collins, T. R. Jones, P. Millet, L. Yuan, G. H. Campbell, R. L. Beaudoin, J. R. Broderson, and S. L. Hoffman. 1991. Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science 251:668-671.
2. Charoenvit, Y., M. L. Leef, L. F. Yuan, M. Sedegah, and R. L. Beaudoin. 1987. Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens. Infect. Immun. 55:604-608.
3. Charoenvit, Y., S. Mellouk, C. Cole, R. Bechara, M. F. Leef, M. Sedegah, L. F. Yuan, F. A. Robey, R. L. Beaudoin, and S. L. Hoffman. 1991. Monoclonal, but not polyclonal antibodies protect against Plasmodium yoelii sporozoites. J. Immunol. 146:1020-1025.
4. Charoenvit, Y., S. Mellouk, M. Sedegah, T. Toyoshima, M. F. Leef, P. De la Vega, R. L. Beaudoin, M. Aikawa, V. Fallarme, and S. L. Hoffman. 1995. Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody. Exp. Parasitol. 80:419-429.
5. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229-1244.
6. Dialynas, D. P., D. B. Wilde, P. Marrack, A. Pierres, K. A. Wall, W. Havran, G. Otten, M. R. Loken, M. Pierres, J. Kappler, and F. Fich. 1983. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK 1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class Il MHC antigen-reactivity. Immunol. Rev. 74:29-54.
7. Doolan, D. L., R. C. Hedstrom, W. O. Rogers, Y. Charoenvit, M. Rogers, P. de la Vega, and S. L. Hoffman. 1996. Identification and characterization of the protective hepatocyte erythrocyte protein 17kDa gene of Plasmodium yoelii, homolog of Plasmodium falcipanim exported protein-1. J. Biol. Chem. 271:17861-17868.
8. + T cells in the Plasmodium yoelii model. J. Immunol. 163:884-892.
9. + T cell-, interferon gamma-, and nitric oxide-dependent immunity. J. Exp. Med. 183: 1739-1746.
10. Egan, J. E., J. L. Weber, W. R. Ballou, M. R. Hollingdale, W. R. Majarian, D. M. Gordon, W. L. Maloy, S. L. Hoffman, R. A. Wirtz, I. Schneider, G. R. Woollett, J. F. Young, and W. T. Hockmeyer. 1987. Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development. Science 236:453-456.
11. Ey, P. L., S. J. Prowse, and C. R. Jenkin. 1978. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry 15:429-436.
12. Hedstrom, R. C., J. R. Campbell, M. L. Leef, Y. Charoenvit, M. Carter, M. Sedegah, R. L. Beaudoin, and S. L. Hoffman. 1990. A malaria sporozoite surface antigen distinct from the circumsporozoite protein. Bull. W. H. O. 68(Suppl.):152-157.
13. Hoffman, S. L., D. L. Doolan, M. Sedegah, R. Gramzinski, H. Wang, K. Gowda, P. Hobart, M. Margalith, J. Norman, and R. C. Hedstrom. 1995. Nucleic acid malaria vaccines: current status and potential. Ann. N. Y. Acad. Sci. 772:88-94.
14. Hoffman, S. L., W. O. Rogers, D. J. Carucci, and J. C. Venter. 1998 From genomics to vaccines: malaria as a model system. Nat. Med. 4:1351-1353.
15. Hoffman, S. L., and J. B. Sacci, Jr. 1995. Rationale and approaches to constructing preerythrocytic malaria vaccines, p. 787-802. In M. F. Powell and M. J. Newman (ed.), Vaccine design: the subunit and adjuvant approach. Plenum Press, New York, N.Y.
16. Houghten, R. A. 1985. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. USA 82: 5131-5135.
17. Mellouk, S., N. Berbiguier, P. Druilhe, M. Sedegah, B. Galey, L. Yuan, M. Leef, Y. Charoenvit, C. Paul, S. L. Hoffman, and R. Beaudoin. 1990. Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites. Bull. W. H. O. 68(Suppl.):52-59.
18. Merrifield, R. B. 1963. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:2149-2154.
19. Migliorini, P., B. Betschart, and G. Corradin. 1993. Malaria vaccine: immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity. Eur. J. Immunol. 23:582-585.
20. Miller, L. H., and S. L. Hoffman. 1998. Research toward vaccines against malaria. Nat. Med. 4(Suppl. 5):520-524.
21. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
22. + T cell clones against Plasmodium yoelii liver stages. J. Immunol. 150:1471-1478.
23. Rogers, W. O., M. D. Rogers, R. C. Hedstrom, and S. L. Hoffman. 1992. Characterization of the gene encoding sporozoite surface protein 2, a protective Plasmodium yoelii sporozoite antigen. Mol. Biochem. Parasitol. 53: 45-52.
24. Sarmiento, M., A. L. Glasebrook, and F. W. Fitch. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing lyt 2 antigen block T-cell mediated cytolysis in the absence of complement. J. Immunol. 125:2665-2672.
25. + T cells and antibodies required for immunity to malaria sporozoites. Nature 330:664-666.
26. + T cells. J. Exp. Med. 180:353-358.
27. Urquiza, M., L. E. Rodriquez, J. E. Suarez, F. Guzman, M. Ocampo, H. Curtidor, C. Segur, E. Trujillo, and M. E. Patarroyo. 1996. Identification of Plasmodium falciparum MSP-1 peptides able to bind to human red blood cells. Parasite Immunol. 18:515-526.
28. Valmori, D., A. Pessi, E. Bianchi, and G. Corradin. 1992. Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J. Immunol. 149:717-721.
29. + T cell and IFN-g dependent elimination of infected hepatocytes. J. Immunol. 157: 4061-4067.
30. Wang, R., Y. Charoenvit, G. Corradin, R. Porrozzi, R. L. Hunter, G. Glenn, C. R. Alving, P. Church, and S. L. Hoffman. 1995. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. J. Immunol. 154:2784-2793.
31. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA 85: 573-576.
32. Voshida, N., R. S. Nussenzweig, P. Potocnjak, V. Nussenzweig, and M. Alkawa. 1980. Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science 207:71-73.